AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11369685
Drug: Long oral
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long oral anticoagulant course (6 months for P-DVT/PE; 12 weeks for C-DVT)
Trial: 11369685
Drug: Short oral
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short oral anticoagulant course
Trial: 11369685
Drug: Long oral
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long oral anticoagulant course
Trial: 9272331
Drug: Whole-cell pertussis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-cell pertussis vaccines
Trial: 2890669
Drug: Bucindolol 100
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 100 mg/d
Trial: 2890669
Drug: Bucindolol 200
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 200 mg/d
Trial: 2890669
Drug: Bucindolol 300
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 300 mg/d
Trial: 6379505
Drug: Propranolol 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 320 mg/d
Trial: 30103679
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (1 mcg/Kg bolus followed by 1 mcg/Kg/hour for 90 min)
Trial: 30103679
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion (Control group)
Trial: 26718688
Drug: RVF MP‐12,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RVF MP‐12, administered subcutaneously (SQ) at a concentration of 10(4.7) plaque‐forming units (pfu)
Trial: 26718688
Drug: RVF MP‐12,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RVF MP‐12, administered intramuscularly (IM) at 10(3.4) pfu (IM Group 1)
Trial: 26718688
Drug: RVF MP‐12,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RVF MP‐12, administered IM at 10(4.4) pfu (IM Group 2)
Trial: 22965404
Drug: Colonic irrigation
RxNorm normalized name: Sus scrofa colon preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colonic irrigation and oral antibiotics (1 L of tap water daily and a 1-week course of ciprofloxacin and metronidazole)
Trial: 20944503
Drug: d-amphetamine (8,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (8, 16, and 24 mg)
Trial: 20944503
Drug: d-amphetamine (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (0, 8, 16, and 24 mg)
Trial: 18977988
Drug: Prophylaxis (co-trimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis (co-trimoxazole 15 mg/kg per day or co-amoxiclav 15 mg/kg per day for 12 months)
Trial: 16443054
Drug: Adapalene gel
RxNorm normalized name: Adapalene Gel
DrugBank: Adapalene (DB00210)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adapalene gel 0.3%
Trial: 10518234
Drug: 50 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/m2 intramuscular methotrexate on day 1
Trial: 10518234
Drug: 50 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/m2 intramuscular methotrexate followed by 800 micrograms vaginal misoprostol 3 days later
Trial: 7898846
Drug: Low-dose monophasic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose monophasic oral contraceptives (OCs)
Trial: 7898846
Drug: No OCs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No OCs or other hormonally active medications
Trial: 1456487
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with wheat flour
Trial: 6697889
Drug: Timed-release tablet
RxNorm normalized name: RITE AID Natural Vitamin B-12 1000mcg Timed-Release Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timed-release tablet containing carbinoxamine maleate 8 mg and pseudoephedrine hydrochloride 120 mg
Trial: 6697889
Drug: Timed-release tablet
RxNorm normalized name: RITE AID Natural Vitamin B-12 1000mcg Timed-Release Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timed-release tablet
Trial: 17250613
Drug: Gabapentin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (up to 1,200 mg)
Trial: 15748221
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of hyperhomocysteinemia
Trial: 9682390
Drug: SB DTaP
RxNorm normalized name: SB 224289
DrugBank: SB 224289 (DB17052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB DTaP vaccine
Trial: 9682390
Drug: CB DTaP
RxNorm normalized name: BroveX CB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CB DTaP vaccine
Trial: 7800902
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg p.o. plus metoclopramide 10 mg p.o. (metoclopramide group, n = 322)
Trial: 7800902
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg p.o. (control group, n = 315)
Trial: 3153710
Drug: Yohimbine (YOH)
RxNorm normalized name: YOHIMBINE
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (YOH) 0.8 mg/kg
Trial: 2878812
Drug: Diazepam (DZ)
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam (DZ) 0.3 mg/kg
Trial: 31822251
Drug: Intravenous alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alteplase (doses not specified)
Trial: 29182412
Drug: Water loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water loading (100 ml/kg for Days 1-3, 15 ml/kg on Day 4)
Trial: 26248357
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg cadazolid BID
Trial: 26248357
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg cadazolid BID
Trial: 26248357
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg cadazolid BID
Trial: 26248357
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg vancomycin QID
Trial: 23347400
Drug: Ultra-low-dose vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-low-dose vaginal estriol 0.03 mg in combination with Lactobacillus acidophilus KS400 (Gynoflor(®) vaginal tablets)
Trial: 23347400
Drug: Ultra-low-dose vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-low-dose vaginal estriol 0.03 mg in combination with Lactobacillus acidophilus KS400 (Gynoflor(®) vaginal tablets) during maintenance therapy
Trial: 18226399
Drug: Intravenous N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous N-acetylcysteine (NAC) during hemodialysis
Trial: 16606393
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose fluoroscopy regime
Trial: 8772759
Drug: Propafenone 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 750 mg/day for 48 hours before cardioversion
Trial: 1408320
Drug: Acetaminophen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1000 mg, orally)
Trial: 1408320
Drug: Antipyrine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine (1000 mg, orally)
Trial: 3892996
Drug: Intravenous indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous indomethacin 100 mg
Trial: 31533906
Drug: Patiromer (8·4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patiromer (8·4 g once daily)
Trial: 3946771
Drug: Hyoscine patch
RxNorm normalized name: HYOSCINE HYDROBROMIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine patch
Trial: 27385502
Drug: Topical high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical high-dose combination of clonidine (0.1%) + pentoxifylline (5%)
Trial: 27385502
Drug: Topical low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical low-dose combination of clonidine (0.04%) + pentoxifylline (2%)
Trial: 27385502
Drug: Placebo treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatments for both low-dose and high-dose combinations
Trial: 27385502
Drug: High-dose combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose combination of clonidine + pentoxifylline
Trial: 15892287
Drug: Qingyuan decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingyuan decoction combined with antibiotics
Trial: 10428519
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg aspirin daily for > or = 14 days
Trial: 2298828
Drug: Nimodipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (2 mg/h constant i.v. infusion for 5 days, 120 mg/day orally for another 16 days)
Trial: 12085574
Drug: Glass syringes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glass syringes with daily new needles
Trial: 31683132
Drug: Progressive Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progressive Muscle Relaxation (PMR) and music therapy
Trial: 26467764
Drug: 12 sessions
RxNorm normalized name: Alpinia Sessilis Root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 sessions of aerobic exercise at preferred intensity alongside treatment as usual
Trial: 26467764
Drug: treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment as usual only
Trial: 23300303
Drug: Bacillus subtilis
RxNorm normalized name: Bacillus Subtilis
DrugBank: Bacillus subtilis (DB11347)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus subtilis PB6 at 500 g/t of feed, containing 5 × 10(11) cfu/kg
Trial: 11494935
Drug: Antidepressant prescribing
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant prescribing practices by nurse practitioners
Trial: 9269644
Drug: Amino/Bic (1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino/Bic (1% amino acid, 34 mmol/l bicarbonate)
Trial: 9269644
Drug: Glu/Bic (1.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glu/Bic (1.5% glucose, 34 mmol/l bicarbonate)
Trial: 9269644
Drug: Glu/Lac (1.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glu/Lac (1.5% glucose, 35 mmol/l lactate)
Trial: 3126508
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g l-carnitine (endovenous)
Trial: 25985369
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (eccentric exercise regime under physiotherapeutic supervision)
Trial: 25034509
Drug: Rectal NSAID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal NSAID
Trial: 15970918
Drug: Around-the-clock (ATC)
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Around-the-clock (ATC) dosing of acetaminophen with codeine
Trial: 15970918
Drug: As-needed (PRN)
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: As-needed (PRN) dosing of acetaminophen with codeine
Trial: 12775122
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g MCT (10M)
Trial: 12775122
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g MCT and 5 g LCT (5M5L)
Trial: 12775122
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g MCT in mayonnaise or margarine
Trial: 12775122
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g LCT (10L)
Trial: 7744189
Drug: Low-dose methylprednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methylprednisolone (1 mg.kg‐1 q.d.)
Trial: 7744189
Drug: High-dose methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methylprednisolone (6 mg.kg‐1 q.d.)
Trial: 16296709
Drug: Amlodipine 1.25
RxNorm normalized name: levamlodipine 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 1.25 mg once daily
Trial: 16296709
Drug: Amlodipine 2.5
RxNorm normalized name: amlodipine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 2.5 mg once daily
Trial: 6125171
Drug: Metoprolol 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 150 mg twice daily
Trial: 3540229
Drug: Pindolol 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 7.5 mg twice daily
Trial: 30378136
Drug: Simulated fine
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated fine fragrance containing Lim‐OOHs at 1260 ppm (3.0 μg/cm2)
Trial: 30378136
Drug: Simulated fine
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated fine fragrance containing Lim‐OOHs at 420 ppm (0.99 μg/cm2)
Trial: 30378136
Drug: Simulated fine
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated fine fragrance containing Lim‐OOHs at 140 ppm (0.33 μg/cm2)
Trial: 30378136
Drug: Healthy controls
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy controls exposed to the highest dose (1260 ppm)
Trial: 28893134
Drug: Mepolizumab (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab (100 mg)
Trial: 11474056
Drug: SACA -
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SACA - administered to children aged 11 and older
Trial: 11474056
Drug: SACA -
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SACA - administered to children aged 9 and 10 years
Trial: 27183915
Drug: Ligation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ligation of the appendicular base with Lapro‐Clips (L‐C group)
Trial: 24355439
Drug: Probiotic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplementation (Lactobacillus casei 01, 10^8 CFU daily for 8 weeks)
Trial: 22536930
Drug: Both antiretroviral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both antiretroviral and antidepressant treatment
Trial: 22536930
Drug: Antidepressant adherence
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant adherence
Trial: 20660052
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (25, 50, 125, 300, and 600 mg) administered weekly for 20 weeks
Trial: 15735108
Drug: DMM (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMM (daily multiple micronutrient supplements)
Trial: 15735108
Drug: DI (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DI (10 mg of iron supplement daily)
Trial: 15735108
Drug: Placebo (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (daily placebo supplement)
Trial: 12846338
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg once daily for 12 weeks
Trial: 10228127
Drug: Inhaled leukotriene
RxNorm normalized name: Leukotriene D4
DrugBank: Leukotriene D4 (DB11858)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled leukotriene D4 (LTD4)
Trial: 8689812
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg itraconazole orally once a day for 4 days
Trial: 2014978
Drug: No antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antimicrobial agent (Control)
Trial: 30648627
Drug: oral ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral ibandronate (150 mg)
Trial: 24286286
Drug: Polychromatic light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polychromatic light treatment (611-650 nm or 570-850 nm, normalized to ∼ 9 J/cm²)
Trial: 22316322
Drug: Nutritional intervention
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional intervention (energy‐ and protein‐enriched diet, oral nutritional supplements, calcium‐vitamin D supplement, telephone counseling by a dietitian) for 3 months after discharge
Trial: 12045414
Drug: Various controller
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various controller medications for asthma treatment; specific medications and dosages not mentioned
Trial: 26636532
Drug: Eumastós (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eumastós (combination of boswellic acid, betaine, and myo-inositol)
Trial: 8405011
Drug: Caffeine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (250 mg capsule) after 48 h abstention
Trial: 8405011
Drug: Caffeine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (250 mg capsule) after 12 h abstention
Trial: 1881996
Drug: Caffeine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (250 mg capsule)
Trial: 3950073
Drug: Cimetidine 300
RxNorm normalized name: cimetidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 300 mg every 6 hours
Trial: 30059240
Drug: Virtual reality-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality-based cue exposure therapy (VR-CET)
Trial: 30059240
Drug: Additional cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional cognitive behavioral therapy (A-CBT)
Trial: 18094990
Drug: Oral antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotic prophylaxis (gyrase inhibitor)
Trial: 18094990
Drug: Intravenous antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotic prophylaxis (gyrase inhibitor)
Trial: 15933555
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose HRV vaccine (10 focus-forming units)
Trial: 15933555
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose HRV vaccine (10 focus-forming units)
Trial: 14569951
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg, increased to 100 mg if unsatisfactory response)
Trial: 11452854
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of rt‐PA intraoperative injection into the opened basal subarachnoid cisterns following aneurysm clipping
Trial: 11452854
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no rt‐PA treatment)
Trial: 19453623
Drug: Ketoconazole treatment
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole treatment (3 and 6 months)
Trial: 19453623
Drug: Ketoconazole treatment
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole treatment (6 months)
Trial: 8803897
Drug: Chloroquine diphosphate
RxNorm normalized name: CHLOROQUINE DIPHOSPHATE, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine diphosphate (CDP) 250 mg/day
Trial: 30041682
Drug: Citrus aurantium
RxNorm normalized name: Citrus aurantium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrus aurantium + Caffeine (CA + C) (100 mg of CA and 100 mg of C)
Trial: 15715187
Drug: Budesonide (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (800 microg twice daily for 4 weeks)
Trial: 11966502
Drug: 28 tablets
RxNorm normalized name: RED 28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 28 tablets (42 g) of sodium phosphate
Trial: 11966502
Drug: 32 tablets
RxNorm normalized name: phosphorus 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 tablets (48 g) of sodium phosphate
Trial: 2405462
Drug: Betadine solution
RxNorm normalized name: Betadine Solution 10% SwabAid
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betadine solution standardized
Trial: 31826369
Drug: 12.5% oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5% oral carbohydrate drink
Trial: 21411615
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (double-strength, 54% juice, 835 mg total polyphenols, 94 mg anthocyanins, 480 mL/d for 4 weeks)
Trial: 21411615
Drug: Placebo beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverage (480 mL/d for 4 weeks)
Trial: 21411615
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (single 480-mL portion)
Trial: 11392270
Drug: Drifting sinusoidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drifting sinusoidal grating background stimulation during computer game training for 10 days (2 sessions of 20 minutes daily)
Trial: 11392270
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group with neutral background during computer game training for 10 days (2 sessions of 20 minutes daily)
Trial: 9271751
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of blood conservation strategies; specific interventions not detailed.